|
|
|
Corporate Profile: Acura
Pharmaceuticals
| Summary: |
| The
focus of Acura Pharmaceuticals is the research and
development of proprietary formulation technologies
intended to deter the abuse of orally administered
opioid analgesic products. |
| Address: |
616 N. North Court
Suite 120
Palatine, IL 60067 |
16235 SR-17
Culver, IN 46511 |
| Phone
#'s: |
| Main |
(847) 705-7709 |
(574) 842-3305 |
| Human
Resources |
not known |
not known |
| Investor
Relations |
not known |
not known |
| Fax
#'s: |
| Main |
(847) 705-5399 |
(574) 842-2519 |
| Human
Resources |
not known |
not known |
| Investor
Relations |
not known |
not known |
| email: |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| ACUR |
| Patent
position: |
| U.S.
patents: 1976-present: patent
link. |
|
|
|
